The Mytos Platform is infrastructure for fully automated manufacture of any human cell type
For traditional drugs, cells are the testbed. For Cell Therapies, cells are the medicine.
$5B
40,000 machines worth of cell production across drug development
$8B
2 million patient cell batches a year by 2030
Platform grows primary suspension cells
Platform grows iPSCs - the hardest to grow human cell type
Final pre-launch pilots
General release of the Mytos Platform
Bringing together some of the best hardware engineers, software engineers, and biologists to invent the infrastructure for biotech.
.jpg)
